| Evaluating reproducibility of differential expression discoveries in microarray studies by considering correlated molecular changes M Zhang, L Zhang, J Zou, C Yao, H Xiao, Q Liu, J Wang, D Wang, C Wang, ... Bioinformatics 25 (13), 1662-1668, 2009 | 142 | 2009 |
| Apparently low reproducibility of true differential expression discoveries in microarray studies M Zhang, C Yao, Z Guo, J Zou, L Zhang, H Xiao, D Wang, D Yang, ... Bioinformatics 24 (18), 2057-2063, 2008 | 140 | 2008 |
| Identification and construction of combinatory cancer hallmark–based gene signature sets to predict recurrence and chemotherapy benefit in stage II colorectal cancer S Gao, C Tibiche, J Zou, N Zaman, M Trifiro, M O’Connor-McCourt, ... JAMA oncology 2 (1), 37-45, 2016 | 136 | 2016 |
| High efficiency error suppression for accurate detection of low-frequency variants TT Wang, S Abelson, J Zou, T Li, Z Zhao, JE Dick, LI Shlush, TJ Pugh, ... Nucleic acids research 47 (15), e87-e87, 2019 | 97 | 2019 |
| GO-function: deriving biologically relevant functions from statistically significant functions J Wang, X Zhou, J Zhu, Y Gu, W Zhao, J Zou, Z Guo Briefings in bioinformatics 13 (2), 216-227, 2012 | 85 | 2012 |
| Cancer systems biology in the genome sequencing era: part 1, dissecting and modeling of tumor clones and their networks E Wang, J Zou, N Zaman, LK Beitel, M Trifiro, M Paliouras Seminars in cancer biology 23 (4), 279-285, 2013 | 79 | 2013 |
| Cancer systems biology in the genome sequencing era: part 2, evolutionary dynamics of tumor clonal networks and drug resistance E Wang, J Zou, N Zaman, LK Beitel, M Trifiro, M Paliouras Seminars in cancer biology 23 (4), 286-292, 2013 | 75 | 2013 |
| Tumor-naïve multimodal profiling of circulating tumor DNA in head and neck squamous cell carcinoma JM Burgener, J Zou, Z Zhao, Y Zheng, SY Shen, SH Huang, S Keshavarzi, ... Clinical Cancer Research 27 (15), 4230-4244, 2021 | 73 | 2021 |
| Deficiency of the chromatin regulator BRPF1 causes abnormal brain development L You, J Zou, H Zhao, NR Bertos, M Park, E Wang, XJ Yang Journal of Biological Chemistry 290 (11), 7114-7129, 2015 | 64 | 2015 |
| Cancer biomarker discovery for precision medicine: new progress J Zou, E Wang Current medicinal chemistry 26 (42), 7655-7671, 2019 | 62 | 2019 |
| HPV sequencing facilitates ultrasensitive detection of HPV circulating tumor DNA E Leung, K Han, J Zou, Z Zhao, Y Zheng, TT Wang, A Rostami, LL Siu, ... Clinical Cancer Research 27 (21), 5857-5868, 2021 | 53 | 2021 |
| Association of germline variants in natural killer cells with tumor immune microenvironment subtypes, tumor-infiltrating lymphocytes, immunotherapy response, clinical outcomes … X Xu, J Li, J Zou, X Feng, C Zhang, R Zheng, W Duanmu, A Saha-Mandal, ... JAMA network open 2 (9), e199292-e199292, 2019 | 44 | 2019 |
| The chromatin regulator Brpf1 regulates embryo development and cell proliferation L You, K Yan, J Zou, H Zhao, NR Bertos, M Park, E Wang, XJ Yang Journal of Biological Chemistry 290 (18), 11349-11364, 2015 | 44 | 2015 |
| BRPF1 is essential for development of fetal hematopoietic stem cells L You, L Li, J Zou, K Yan, J Belle, A Nijnik, E Wang, XJ Yang The Journal of Clinical Investigation 126 (9), 3247-3262, 2016 | 43 | 2016 |
| Multi-level reproducibility of signature hubs in human interactome for breast cancer metastasis C Yao, H Li, C Zhou, L Zhang, J Zou, Z Guo BMC systems biology 4, 1-10, 2010 | 38 | 2010 |
| Germline variants associated with leukocyte genes predict tumor recurrence in breast cancer patients JS Milanese, C Tibiche, J Zou, Z Meng, A Nantel, S Drouin, R Marcotte, ... NPJ precision oncology 3 (1), 28, 2019 | 21 | 2019 |
| eTumorType, An algorithm of discriminating cancer types for circulating tumor cells or cell-free DNAs in blood J Zou, E Wang Genomics, Proteomics and Bioinformatics 15 (2), 130-140, 2017 | 21 | 2017 |
| Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML T Murphy, J Zou, GS Daher-Reyes, A Arruda, V Gupta, CJ McNamara, ... Blood Advances 3 (15), 2307-2311, 2019 | 20 | 2019 |
| Reproducible cancer biomarker discovery in SELDI-TOF MS using different pre-processing algorithms J Zou, G Hong, X Guo, L Zhang, C Yao, J Wang, Z Guo PLoS One 6 (10), e26294, 2011 | 20 | 2011 |
| Systematic interpretation of comutated genes in large-scale cancer mutation profiles Y Gu, D Yang, J Zou, W Ma, R Wu, W Zhao, Y Zhang, H Xiao, X Gong, ... Molecular cancer therapeutics 9 (8), 2186-2195, 2010 | 20 | 2010 |
